The Michigan Prostate Score (MiPS) is a urine-based test that combines PSA with two urinary biomarkers for prostate cancer—urinary Prostate cancer antigen 3 (PCA3) mRNA and urinary TMPRSS2: ERG gene fusion. This evidence concerns the gene PCA3 and prostate carcinoma.